Cargando…
Corrigendum to “Interleukin-9 Deletion Relieves Vascular Dysfunction and Decreases Blood Pressure via the STAT3 Pathway in Angiotensin II-Treated Mice”
Autores principales: | Yang, Yunzhao, Tang, Shaoqun, Zhai, Chunchun, Zeng, Xin, Liu, Qingjian, Xu, Cheng, Chen, Hexiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669330/ https://www.ncbi.nlm.nih.gov/pubmed/33223958 http://dx.doi.org/10.1155/2020/8537832 |
Ejemplares similares
-
Interleukin-9 Deletion Relieves Vascular Dysfunction and Decreases Blood Pressure via the STAT3 Pathway in Angiotensin II-Treated Mice
por: Yang, Yunzhao, et al.
Publicado: (2020) -
Corrigendum: Salvianolic acid B decreases interleukin-1β-induced colitis recurrence in mice
Publicado: (2023) -
Corrigendum to “Ethnic differences in the association between angiotensin-converting enzyme gene insertion/deletion polymorphism and peripheral vascular disease: A meta-analysis” [CDTM 3/4 (2017) 230–241]
por: Han, Chao, et al.
Publicado: (2018) -
Corrigendum to “Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2”
por: Wang, Yong, et al.
Publicado: (2019) -
Corrigendum to “Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema”
por: Rasmussen, Eva Rye, et al.
Publicado: (2018)